The import of tetracyclines to the US is forecasted to grow steadily from 2024 to 2028, with values anticipated to rise from 5.3104 million kilograms in 2024 to 5.6685 million kilograms by 2028. In 2023, the import volume stood at 5.2300 million kilograms. The year-on-year variation shows a consistent growth rate of approximately 1.7% annually. Over the five-year forecast period, the compound annual growth rate (CAGR) is projected at around 1.64%, indicating a stable upward trend in import volume.
Future trends to watch for include potential impacts of global supply chain dynamics, regulatory changes, and domestic production capabilities on tetracycline imports. Additionally, shifts in demand within the healthcare and veterinary sectors could influence future import volumes.
